Search Results
Dec 08, 2025, 10:50 ET Nutraceutical Excipients Market Driven by Expanding Dietary Supplement Demand and Advanced Formulation Technologies - Market Research Intellect
multi-active blends, and personalized packaging formats are increasingly in demand. Companies developing tailored health kits, DNA-based supplements, and age-specific formulations rely on excipients that ensure stability and consistency across numerous product variations. Additionally, the rise of subscription-based
More news about: Market Research Intellect
Dec 08, 2025, 10:20 ET Tax Preparation Software Market to Reach $17.6 billion by 2024 in the short term and $43 billion by 2034 Globally, at 9.2% CAGR: Allied Market Research
(PAYD), Pay-How-You-Drive (PHYD), Manage-How-You-Drive (MHYD)), by Technology (OBD (On-Board Diagnostics)-II, Smartphone, Hybrid, Black Box), by Vehicle Age (New Vehicles, Used Vehicles), by Vehicle Type (Light-Duty Vehicle (LDV), Heavy-Duty Vehicle (HDV)): Global Opportunity Analysis and Industry Forecast,
More news about: Allied Market Research
Dec 08, 2025, 10:09 ET DECEMBER HARVARD CAPS / HARRIS POLL: TRUMP APPROVAL RATING RESETS TO 47% POST-SHUTDOWN; AFFORDABILITY AND INFLATION TOP ECONOMIC WORRIES HEADING INTO 2026
voters support Trump's deal to secure the safe return of Israeli hostages and end hostilities in Gaza, including a majority across political parties and age groups.68% of voters support Trump's 21-point peace plan for Gaza. When given more details about the plan, 78% support it. 58% of voters say
More news about: Stagwell Inc.
Dec 08, 2025, 10:00 ET Gen X Underestimated Retirement. Now, They're Not Sure They Can Catch Up
Gen Xers say they didn't feel their retirement was an urgent priority, rather a distant milestone, until age 50 or older. Moreover, about a quarter (26%) say they won't reach that point until age 60 or older. This delayed awareness has created a domino effect. Many Gen Xers now feel like they're
More news about: Nationwide
Dec 08, 2025, 10:00 ET Axiad Names Accenture Customer of the Year
This close collaboration between a cybersecurity pioneer and a global enterprise demonstrates an effective strategy for tackling a critical digital-age challenge: comprehensively securing every user, credential, and system without hindering innovation.About AxiadAxiad is an identity
More news about: Axiad IDS, Inc.
Dec 08, 2025, 10:00 ET Study Reveals AltaMed Health Services Generated $15.1 Billion in Economic Impact While Caring for Hundreds of Thousands of Southern California Patients Demonstrating How Healthy Communities Strengthen Local Economies
data, AltaMed operates more than 60 accredited health centers and service facilities and remains committed and ready to help you grow healthy at any age. For more information, visit
More news about: AltaMed Health Services
Dec 08, 2025, 09:01 ET Massage Envy Announces Scholarship Sweepstakes Winners
help them grow into the leaders we know they'll become."To be eligible to enter for a chance to win a scholarship, entrants must be of legal age in their state. Entrants only need to enter once. To learn more about the scholarship program or to enter, please go to
More news about: Massage Envy
Dec 08, 2025, 09:00 ET Viral culture is quietly rewriting the economics of travel, Going's 2026 report finds
stage for 2026: a year where strategic planning can save travelers more than 40% on airfare even as other prices rise, premium flyers enter a golden age, and travel as a whole moves out of overdrive and into refocus mode. And beneath it all, one force is quietly becoming more prevalent: the trendification
More news about: Going
Dec 08, 2025, 09:00 ET Lunit Submits 510(k) Application for Image-Based Breast Cancer Risk Prediction Model
with 5-year AUCs up to 0.80 across diverse screening populations in the U.S. and Canada. These studies also showed consistent performance regardless of age, race, or breast density, supporting its potential for equitable clinical adoption."Image-based risk assessment represents an important step toward
More news about: Lunit
Dec 08, 2025, 09:00 ET Abbott's Lingo™ Now on Android™, Expanding Access to Real-Time Glucose Data
informed choices that help support better energy, sleep, focus and overall well-being.i ii iii Lingo is for individuals 18 years of age or older and not on insulin who want to make informed decisions about their health. By showing how food, movement and stress affect glucose in real time,
More news about: Abbott
Dec 08, 2025, 09:00 ET Monster Energy's Joshua Van Defeats Alexandre Pantoja to Claim UFC Flyweight World Championship Title at UFC 323
the UFC Flyweight World Championship title at UFC 323."I'm so blessed. People of Myanmar, now the world will know of us," said Van.At age 24, Van is now the second-youngest champion in UFC history. Born in Myanmar and now fighting out of Houston, he remains undefeated for six consecutive
More news about: Monster Energy
Dec 08, 2025, 08:57 ET Corma Announces €3.5M Seed Round to Revolutionize Software License and Access Governance
boost productivity. Built with an international vision from the start, Corma enables teams to work better, focus on what matters, and thrive in the age of AI. For more information, visit Corma's website:
More news about: Corma
Dec 08, 2025, 08:45 ET WorkWhile Elevates Alan Armen to Chief Economist and Head of Data Science; Launches New WorkWhile Econ Lab Headed by Dr. Debora Loccisano
establish and lead initiatives with researchers, policymakers, regulatory bodies, and industry experts to shape informed policy around labor in the age of AI."The hourly labor market is undergoing a seismic shift driven by new technology and changing worker expectations," said Alan Armen. "The
More news about: WorkWhile
Dec 08, 2025, 08:37 ET Pusan National University Study Highlights the Health Hazards of Ultrafine Particles from Small Home Appliances with Electric Heating Coils and Brushed DC Motors
heating components to minimize UFP emissions from the products."Our study emphasizes the need for emission-aware electric appliance design and age-specific indoor air quality guidelines. In the long term, reducing UFP emissions from everyday devices will contribute to healthier indoor environments
More news about: Pusan National University
Dec 08, 2025, 08:30 ET TESTBOARD Flips the Script on Discovery in the Age of Algorithms
TESTBOARD is built from decades of shaping talent in fashion, film, music, and entertainment—reviving a process the industry once relied on before the age of social media."TESTBOARD is the professional record of emerging talent—an IMDB for the next generation of creators," says Flutie. "But unlike
More news about: TESTBOARD
Dec 08, 2025, 08:00 ET Make-A-Wish Brings Back The Holiday Wish Line with Heartfelt Messages from Wish Kids Nationwide
Colorado.Ruby, age 5, a liver transplant recipient, who fulfilled her wish of publishing a children's book to inspire courage in others.Braedyn, age 8, fighting leukemia, who rediscovered joy and freedom through the simple magic of ice skating.Vera, age 9, living with
More news about: MAKE-A-WISH AMERICA
Dec 08, 2025, 08:00 ET Pierre Fabre Pharmaceuticals Announces Updated Phase 3 Tabelecleucel Data at American Society of Hematology Meeting in Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)
graft vs host disease or organ rejection were reported as tabelecleucel related.A new sub-analysis of 12 pediatric patients less than 17 years of age found the ORR was 50.0% with complete response reported in 4 of 12 patients, and partial response observed in 2 of 12 patients. Efficacy and safety observed
More news about: Pierre Fabre Pharmaceuticals
Dec 08, 2025, 07:30 ET Recordati Rare Diseases Showcases Real-World Evidence Studies That Advance Understanding of Castleman Disease (CD) at the American Society of Hematology (ASH) Annual Meeting
(iMCD)Idiopathic multicentric Castleman disease is a rare cytokine-driven disorder that may be life-threatening and can affect people of any age. Its symptoms often resemble those of malignant lymphoma, autoimmune, or infectious diseases, making it difficult to diagnose. iMCD is a subtype of Castleman
More news about: Recordati
Dec 08, 2025, 07:00 ET UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduced countable motor seizure frequency in CDKL5 deficiency disorder
live births, with a median age of seizure onset of six weeks.3,4,5,6,7,8In the United States, fenfluramine oral solution is indicated for the treatment of seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients 2 years of age and older.9 It
More news about: UCB
Dec 08, 2025, 06:50 ET Manipal Hospitals Enhances Movement and Confidence Through Awareness on Movement Disorders
that makes routine morning walks more challenging, or a brief loss of balance that is easy to dismiss. Most people attribute these changes to age or tiredness.
More news about: Manipal Hospitals
Dec 08, 2025, 04:00 ET A Chase Spanning Half a Century! WePlay Teams Up with Beloved Russian Cartoon "Just You Wait!" for a New Year's Adventure
rivalry between the unlucky grey wolf and the clever hare, is not only a childhood memory for generations but also maintains remarkable vitality in the age of social media. By introducing this IP at the turn of the New Year, WePlay aims to leverage its humor that transcends language and borders, and its
More news about: WePlay
Dec 08, 2025, 01:32 ET UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder
with a median age of onset of six weeks.3,4,5,6,7In the European Union (EU), fenfluramine is approved for the treatment of seizures associated with Dravet syndrome and Lennox-Gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.8
More news about: UCB
Dec 08, 2025, 01:28 ET UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder
with a median age of onset of six weeks.3,4,5,6,7In the European Union (EU), fenfluramine is approved for the treatment of seizures associated with Dravet syndrome and Lennox-Gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.8
More news about: UCB
Dec 07, 2025, 20:02 ET ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma
study design.A total of 39 patients were enrolled in this phase in China and Australia, with a dose range of 0.1 μg/kg to 800 μg/kg. The median age of patients was 62 years (range: 40-79), 64.1% of whom were classified as high-risk per mSMART criteria, and 46.2% had ≥1 EMD. The median number of prior
More news about: Innovent Biologics
Dec 07, 2025, 20:00 ET Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others
the January-May 2024 period in DRC indicated that 62% of the fatalities occurred in children aged under 5 years, where the case fatality ratio in this age group ranged from approximately 7 to 9%4. Due to the sharp increase in cases, a Public Health Emergency of International Concern (PHEIC) was
More news about: GHIT Fund